#USA #Seattle #HoneyNaps #SOMNUM™ #AI Sleep Tech

HoneyNaps Unveils SOMNUM™ Cloud at SLEEP 2025

HoneyNaps, a pivotal player in medical AI diagnostics, has made waves at the SLEEP 2025 conference held in Seattle, showcasing its groundbreaking cloud-based sleep diagnostic software, SOMNUM™ Cloud. The event is renowned for being the largest global platform dedicated to sleep medicine and was attended by around 5,000 sleep professionals from across the globe.

Leading the Charge in AI Sleep Diagnostics

For the fourth consecutive year, HoneyNaps represented Korea at this prestigious event, reinforcing the company’s commitment to innovation in sleep research. During the conference, they presented significant advancements in sleep diagnostics, highlighted by a deep learning model aimed at accurately classifying sleep stages using ECG signals. This novel approach promises to enhance diagnostic accuracy when compared to traditional methods.

In a demonstration that captivated the audience, HoneyNaps showcased the SOMNUM™ Cloud, designed for automated analysis of polysomnography (PSG) data. This cutting-edge tool allows users to upload PSG data files directly to the cloud, where a powerful AI engine performs analyses and produces detailed reports. Importantly, this service is entirely web-based, negating the need for software installation, thereby streamlining the user experience considerably.

Hands-On Experience at SLEEP 2025

To further enhance the conference experience, HoneyNaps provided attendees with a unique opportunity to try out the SOMNUM™ Cloud through an AI trial service. Participants could access up to three free analyses, helping them to witness firsthand the potential of this advanced diagnostic tool in a simulated clinical environment. The response from American sleep physicians and Registered Polysomnographic Technologists (RPSGTs) was overwhelmingly positive, reflecting the tool's effectiveness and the keen interest it generated.

Dr. Taekyoung (Sean) Ha, President of HoneyNaps USA, expressed excitement about the potential for collaborations, noting that more than 100 medical institutions in the United States have shown interest in adopting this innovative cloud-based service. The ease of implementation, coupled with strict HIPAA compliance, has made SOMNUM™ Cloud appealing for many healthcare providers.

Individual meetings were also held with key players in the global sleep industry, allowing HoneyNaps to explore strategic partnerships that could enhance the reach and impact of its revolutionary technology.

Conclusion

The launch of SOMNUM™ Cloud at SLEEP 2025 marks a significant milestone in HoneyNaps’ ongoing mission to advance sleep medicine through AI innovations. As two of the leading bodies in the field— the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS)— co-host the conference, HoneyNaps’ presence and impact emphasize its role as a torchbearer for emerging technologies in this vital healthcare sector. As we look forward, the anticipated integration of such AI-driven solutions may soon redefine diagnostics and patient care in sleep medicine.

For more detailed information about HoneyNaps and its innovative products, visit their official website or contact them directly.